isoniazid has been researched along with lincomycin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kimbel, KH | 1 |
| Kagan, BM; Levin, HS | 1 |
| Lesar, TS; Zaske, DE | 1 |
| Desai, SG; Lynd, LR; Tyurin, MV | 1 |
2 review(s) available for isoniazid and lincomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibiotics and hepatic disease.
Topics: Aminoglycosides; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Humans; Isoniazid; Kinetics; Lincomycin; Liver Diseases; Penicillins; Rifampin | 1982 |
8 other study(ies) available for isoniazid and lincomycin
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
[Toxicological evaluation criteria (secondary action aspects)].
Topics: Anti-Infective Agents; Cephalosporins; Chloramphenicol; Erythromycin; Ethambutol; Gentamicins; Humans; Isoniazid; Lincomycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Penicillins; Rifampin; Streptomycin; Sulfonamides; Tetracyclines | 1977 |
Antimicrobial agents: pediatric dosage, routes of administration and preparation procedures for parenteral therapy.
Topics: Amphotericin B; Anti-Infective Agents; Bacitracin; Cephalothin; Chloramphenicol; Colistin; Erythromycin; Humans; Isoniazid; Kanamycin; Lincomycin; Neomycin; Nitrofurantoin; Novobiocin; Oleandomycin; Polymyxins; Streptomycin; Sulfadiazine; Sulfisoxazole; Tetracycline; Viomycin | 1968 |
Electrotransformation of Clostridium thermocellum.
Topics: Anti-Bacterial Agents; Clostridium; DNA Primers; Drug Resistance, Bacterial; Electroporation; Erythromycin; Escherichia coli; Gene Transfer Techniques; Isoniazid; Lincomycin; Transformation, Bacterial | 2004 |